Alnylam Pharmaceuticals | ALNY - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
Arrowhead Research USD 218.87M 212.05M 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 186.13M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 158M 45.46M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xencor USD 29.3M 7.49M 2025-12